A Hidden Markov Model for Single Particle Tracks Quantifies Dynamic Interactions between LFA-1 and the Actin Cytoskeleton
Figure 7
Schematic diagram of LFA-1 interactions and experimental conditions.
A schematic diagram showing the putative interaction between LFA-1 and a binding partner (e.g. talin) associated with the actin cytoskeleton, and the pharmacological agents used to perturb the system. cyto D: cytochalasin D; lova: lovastatin; cal-I: calpain inhibitor I. Additionally, PMA was used to activate the cells. See reference [22] for details of treatment conditions.